Sameh Tawfik

Array ( [id] => 5937707 [patent_doc_number] => 20110213011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'MODULATION OF SMAD3 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/035772 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29747 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213011.pdf [firstpage_image] =>[orig_patent_app_number] => 13035772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359698 [patent_doc_number] => 20120214860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'METHOD OF REGULATING THE EXPRESSION LEVEL OF SURVIVAL OF MOTOR NEURON 1 (SMN1) AND DETECTING ENZYME ACTIVITY OF UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L1 (UCHL1)' [patent_app_type] => utility [patent_app_number] => 13/032846 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4415 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538051 [patent_doc_number] => 08313772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Compositions for targeted delivery of siRNA' [patent_app_type] => utility [patent_app_number] => 13/032029 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 24487 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8707954 [patent_doc_number] => 20130065243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/579314 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10732 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164375 [patent_doc_number] => 20110160707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OF HUNTINGTON\'S DISEASE THROUGH INTRACRANIAL DELIVERY OF SIRNA' [patent_app_type] => utility [patent_app_number] => 13/028638 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14227 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160707.pdf [firstpage_image] =>[orig_patent_app_number] => 13028638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651949 [patent_doc_number] => 20110301218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'MODIFIED snRNAs FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 13/025428 [patent_app_country] => US [patent_app_date] => 2011-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17286 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301218.pdf [firstpage_image] =>[orig_patent_app_number] => 13025428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637085 [patent_doc_number] => 20130028889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'DOSING REGIMENS FOR TREATING AND PREVENTING OCULAR DISORDERS USING C-RAF ANTISENSE' [patent_app_type] => utility [patent_app_number] => 13/577219 [patent_app_country] => US [patent_app_date] => 2011-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21542 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018572 [patent_doc_number] => 09061042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Composition for suppressing expression of target gene' [patent_app_type] => utility [patent_app_number] => 13/017562 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 23254 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13017562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696716 [patent_doc_number] => 20110229874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOSITIONS AND METHODS USEFUL FOR HCV INFECTION' [patent_app_type] => utility [patent_app_number] => 13/013758 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8074 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229874.pdf [firstpage_image] =>[orig_patent_app_number] => 13013758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818005 [patent_doc_number] => 20120064625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis' [patent_app_type] => utility [patent_app_number] => 13/007137 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 19499 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064625.pdf [firstpage_image] =>[orig_patent_app_number] => 13007137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190012 [patent_doc_number] => 20110172296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'MODULATION OF TRANSFORMING GROWTH FACTOR-BETA 1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/005508 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32643 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172296.pdf [firstpage_image] =>[orig_patent_app_number] => 13005508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487555 [patent_doc_number] => 20110236427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Antagonists of NR2F6 For Augmenting The Immune Response' [patent_app_type] => utility [patent_app_number] => 13/004781 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 37998 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236427.pdf [firstpage_image] =>[orig_patent_app_number] => 13004781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617328 [patent_doc_number] => 20130022640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'IMMUNE MODULATORS RELATING TO FOXO3A' [patent_app_type] => utility [patent_app_number] => 13/520904 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23251 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951356 [patent_doc_number] => 09000143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Compositions and methods for inhibiting expression of IKK-B gene' [patent_app_type] => utility [patent_app_number] => 12/982261 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 27538 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12982261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8674924 [patent_doc_number] => 08383036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Methods for neutralizing anthrax or anthrax spores' [patent_app_type] => utility [patent_app_number] => 12/973681 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7859 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12973681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6185039 [patent_doc_number] => 20110123998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Materials and Methods for Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/948648 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16266 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123998.pdf [firstpage_image] =>[orig_patent_app_number] => 12948648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6120699 [patent_doc_number] => 20110077173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'siRNA targeting TIE-2' [patent_app_type] => utility [patent_app_number] => 12/927144 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 36001 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077173.pdf [firstpage_image] =>[orig_patent_app_number] => 12927144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370245 [patent_doc_number] => 20120219632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'METHODS FOR MONITORING CELLULAR STATES AND FOR IMMORTALIZING MESENCHYMAL STEM CELL' [patent_app_type] => utility [patent_app_number] => 13/505622 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 41196 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6117731 [patent_doc_number] => 20110191873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Methods of Protein Destabilization and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/938179 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 32164 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20110191873.pdf [firstpage_image] =>[orig_patent_app_number] => 12938179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762307 [patent_doc_number] => 08846630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Pharmaceutical composition for treating cancer' [patent_app_type] => utility [patent_app_number] => 13/512583 [patent_app_country] => US [patent_app_date] => 2010-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 7470 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512583 [rel_patent_id] =>[rel_patent_doc_number] =>)